These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 24085327)
1. All-cause and disease-related health care costs associated with recurrent venous thromboembolism. Lefebvre P; Laliberté F; Nutescu EA; Duh MS; LaMori J; Bookhart BK; Olson WH; Dea K; Hossou Y; Schein J; Kaatz S Thromb Haemost; 2013 Dec; 110(6):1288-97. PubMed ID: 24085327 [TBL] [Abstract][Full Text] [Related]
2. All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries. Lefebvre P; Laliberté F; Nutescu EA; Duh MS; LaMori J; Bookhart BK; Olson WH; Dea K; Schein J; Kaatz S J Manag Care Pharm; 2012 Jun; 18(5):363-74. PubMed ID: 22663169 [TBL] [Abstract][Full Text] [Related]
3. Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population. Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P J Med Econ; 2011; 14(3):324-34. PubMed ID: 21506632 [TBL] [Abstract][Full Text] [Related]
4. In-hospital risk of venous thromboembolism and bleeding and associated costs for patients undergoing total hip or knee arthroplasty. Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P J Med Econ; 2012; 15(4):644-53. PubMed ID: 22356512 [TBL] [Abstract][Full Text] [Related]
5. Healthcare resource utilization and costs associated with venous thromboembolism recurrence in patients with cancer. Khorana AA; McCrae KR; Milentijevic D; Laliberté F; Lejeune D; Crivera C; Lefebvre P J Med Econ; 2020 Apr; 23(4):323-329. PubMed ID: 31818164 [No Abstract] [Full Text] [Related]
6. Venous thromboembolism: annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates. Mahan CE; Borrego ME; Woersching AL; Federici R; Downey R; Tiongson J; Bieniarz MC; Cavanaugh BJ; Spyropoulos AC Thromb Haemost; 2012 Aug; 108(2):291-302. PubMed ID: 22739656 [TBL] [Abstract][Full Text] [Related]
7. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism. White RH; Chan WS; Zhou H; Ginsberg JS Thromb Haemost; 2008 Aug; 100(2):246-52. PubMed ID: 18690344 [TBL] [Abstract][Full Text] [Related]
8. The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs. Grosse SD; Nelson RE; Nyarko KA; Richardson LC; Raskob GE Thromb Res; 2016 Jan; 137():3-10. PubMed ID: 26654719 [TBL] [Abstract][Full Text] [Related]
9. Economic burden of recurrent venous thromboembolism: analysis from a U.S. hospital perspective. Casciano JP; Dotiwala Z; Kemp R; Li C; Cai J; Preblick R Am J Health Syst Pharm; 2015 Feb; 72(4):291-300. PubMed ID: 25631836 [TBL] [Abstract][Full Text] [Related]
10. Clinical burden of venous thromboembolism. Ruppert A; Lees M; Steinle T Curr Med Res Opin; 2010 Oct; 26(10):2465-73. PubMed ID: 20825270 [TBL] [Abstract][Full Text] [Related]
11. Incremental Health Care Burden of Bleeding Among Patients with Venous Thromboembolism in the United States. Amin A; Bruno A; Trocio J; Lin J; Lingohr-Smith M J Manag Care Spec Pharm; 2015 Oct; 21(10):965-72. PubMed ID: 26402395 [TBL] [Abstract][Full Text] [Related]
12. All-cause and incremental per patient per year cost associated with chronic hepatitis C virus and associated liver complications in the United States: a managed care perspective. McAdam-Marx C; McGarry LJ; Hane CA; Biskupiak J; Deniz B; Brixner DI J Manag Care Pharm; 2011 Sep; 17(7):531-46. PubMed ID: 21870894 [TBL] [Abstract][Full Text] [Related]
14. Rates of venous thromboembolism occurrence in medical patients among the insured population. Spyropoulos AC; Hussein M; Lin J; Battleman D Thromb Haemost; 2009 Nov; 102(5):951-7. PubMed ID: 19888534 [TBL] [Abstract][Full Text] [Related]
15. Risk factors associated with myocardial infarction in venous thromboembolism patients. Laliberté F; Nutescu EA; Lefebvre P; Rondeau-Leclaire J; Bookhart BK; LaMori JC; Damaraju CV; Schein J; Kaatz S Curr Med Res Opin; 2014 Jan; 30(1):27-35. PubMed ID: 24102370 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the two-year outcomes and costs of prophylaxis in medical patients at risk of venous thromboembolism. Deitelzweig SB; Becker R; Lin J; Benner J Thromb Haemost; 2008 Nov; 100(5):810-20. PubMed ID: 18989525 [TBL] [Abstract][Full Text] [Related]
17. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry. Linnemann B; Zgouras D; Schindewolf M; Schwonberg J; Jarosch-Preusche M; Lindhoff-Last E Blood Coagul Fibrinolysis; 2008 Mar; 19(2):159-65. PubMed ID: 18277138 [TBL] [Abstract][Full Text] [Related]
18. Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study. Le Moigne E; Delluc A; Tromeur C; Nowak E; Mottier D; Lacut K; Le Gal G Thromb Res; 2013 Jul; 132(1):51-5. PubMed ID: 23786893 [TBL] [Abstract][Full Text] [Related]
19. Impact and cost of care of venous thromboembolism following pituitary surgery. Spinazzi EF; Pines MJ; Fang CH; Raikundalia MD; Baredes S; Liu JK; Eloy JA Laryngoscope; 2015 Jul; 125(7):1563-7. PubMed ID: 25647758 [TBL] [Abstract][Full Text] [Related]
20. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism. Lecumberri R; Alfonso A; Jiménez D; Fernández Capitán C; Prandoni P; Wells PS; Vidal G; Barillari G; Monreal M; Thromb Haemost; 2013 Oct; 110(4):834-43. PubMed ID: 23846721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]